, /PRNewswire/ — Bluesight, the leading provider of inventory management, procurement, and compliance solutions for health systems and hospital pharmacies, today announced the acquisition of Protenus, provider of the leading healthcare compliance analytics platform. This strategic acquisition will further strengthen Bluesight’s drug diversion platform and add critical patient privacy monitoring capabilities to better protect healthcare organizations and the communities they serve.
Protenus leverages artificial intelligence capabilities to provide healthcare organizations with scalable risk-reduction solutions that drive the safest, highest-quality patient outcomes, while protecting their organizations’ reputation. Since its founding in 2014, Protenus has grown into a category leader with strong, trusted relationships with hundreds of healthcare organizations across the United States, supporting them as they navigate and overcome significant operational and reputational risks. This combination will bring together Bluesight’s intelligence that powers hospital and pharmacy operations, and Protenus’ expertise in compliance and risk management, offering a unified platform delivering innovative solutions needed …